文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

脓毒症患者血脂谱与炎症反应及病情严重程度的关系

[The relationship between the lipid profiles and inflammation in patients with sepsis].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2022-01-01
一句话结论脓毒症患者血浆胆固醇(尤其HDL-C)降低,HDL-C与炎症指标及病情严重程度相关,HDL-C≤0.69 mmol/L者28天死亡率显著升高。

该回顾性研究纳入郑州大学第一附属医院重症医学科2019年10月至2021年5月收治的449例脓毒症患者,并以同期355例非脓毒症住院患者为对照,比较入院24小时内血脂等指标。脓毒症患者总胆固醇、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇均显著低于非脓毒症患者。在脓毒症患者中,HDL-C与白细胞介素-6、降钙素原、序贯器官衰竭评估评分的相关性最强。ROC曲线显示HDL-C对28天死亡的预测价值最高,AUC为0.718,最佳截断值0.69 mmol/L。HDL-C≤0.69 mmol/L者28天死亡率、多器官功能障碍发生率、机械通气与血管活性药物使用概率、微生物培养阳性率及耐药菌概率均显著高于HDL-C>0.69 mmol/L者。

要点

  • 脓毒症患者HDL-C≤0.69 mmol/L者28天死亡率为59.73%(135/226),显著高于HDL-C>0.69 mmol/L者的28.70%(64/223),P<0.000 1。
  • HDL-C对脓毒症28天死亡预测的AUC为0.718,最佳截断值0.69 mmol/L时敏感度67.3%、特异度65.2%。
  • 脓毒症患者HDL-C与IL-6(r=-0.551,P=0.000)、降钙素原(r=-0.598,P=0.000)、SOFA评分(r=-0.285,P=0.000)均呈负相关。
  • 脓毒症患者总胆固醇、HDL-C、LDL-C均显著低于非脓毒症对照:TC 2.93±1.33 vs. 4.01±1.14 mmol/L,HDL-C 0.78±0.47 vs. 1.16±0.40 mmol/L,LDL-C 1.53±1.00 vs. 2.71±0.98 mmol/L,均P<0.05。
  • 低HDL-C组(≤0.69 mmol/L)多器官功能障碍发生率41.15%(93/226)vs. 31.84%(71/223),机械通气56.64%(128/226)vs. 46.18%(103/223),血管活性药物54.42%(123/226)vs. 38.57%(86/223),微生物培养阳性45.58%(103/226)vs. 35.43%(79/223),耐药菌19.91%(45/226

适用人群与场景

  • 2019年10月至2021年5月郑州大学第一附属医院重症医学科收治的449例脓毒症患者;以同期355例非脓毒症住院患者为对照。
  • 纳入患者均收集入院24小时内的血脂及其他临床指标。

诊断标准与关键阈值

  • HDL-C预测28天死亡的最佳截断值为0.69 mmol/L(AUC 0.718,敏感度67.3%,特异度65.2%)。

红旗征与不能漏的情况

  • 脓毒症患者HDL-C≤0.69 mmol/L时28天死亡率显著高于HDL-C>0.69 mmol/L者(59.73% vs. 28.70%,P<0.000 1)。

研究设计与关键结果

  • 研究类型:回顾性分析;样本量449例脓毒症患者与355例非脓毒症对照;单中心(郑州大学第一附属医院重症医学科)。
  • 主要结果:脓毒症组TC、HDL-C、LDL-C均显著低于非脓毒症组(TC 2.93±1.33 vs. 4.01±1.14 mmol/L,HDL-C 0.78±0.47 vs. 1.16±0.40 mmol/L,LDL-C 1.53±1.00 vs. 2.71±0.98 mmol/L,均P<0.05)。
  • 相关性:脓毒症患者HDL-C与IL-6(r=-0.551,P=0.000)、PCT(r=-0.598,P=0.000)、SOFA评分(r=-0.285,P=0.000)负相关,为血脂各成分中相关性最强者。
  • 预测价值:HDL-C对28天死亡的AUC最高,为0.718;最佳截断值0.69 mmol/L时敏感度67.3%、特异度65.2%,阳性预测值60.6%、阴性预测值71.5%。
  • 生存分析:HDL-C≤0.69 mmol/L组28天累积生存率(无终点事件)显著低于HDL-C>0.69 mmol/L组(P<0.000 1)。
  • 低HDL-C组(≤0.69 mmol/L,n=226)与高HDL-C组(>0.69 mmol/L,n=223)比较:28天死亡率59.73%(135/226)vs. 28.70%(64/223);多器官功能障碍发生率41.15%(93/226)vs. 31.84%(71/223);需机械通气56.64%(128/226)vs. 46.18%(103/223);需血管活性药物54.42%(123/226)vs. 38.57%(86/223);微生物培养阳性率45.58%(103/226)vs. 35.43%(79/223);耐药菌概率19.91%(45/226)vs. 10.31%(23/223);以上差异均有统计学意义(均P<0.05)。

证据类型、等级与局限

  • 证据类型:回顾性分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,血浆胆固醇水平(尤其HDL-C)能较好地反映脓毒症患者的炎症反应强度和病情严重程度,HDL-C可作为预测脓毒症短期预后的良好生物标志物。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To explore the relationship between the changes in the lipid profiles and the intensity of inflammatory response and disease severity in patients with sepsis, in order to find a biomarker that can quickly evaluate the condition and prognosis of sepsis.

METHODS: A retrospective analysis was performed on 449 patients with sepsis admitted to department of critical care medicine of the First Affiliated Hospital of Zhengzhou University from October 2019 to May 2021, and 355 patients without sepsis hospitalized in the same period served as the control. The general demographic data, blood lipid and other clinical indicators within 24 hours after admission were collected and compared between the two groups. Bivariate correlation study was used to analyze the relationship between blood lipid levels and inflammation indicators and severity of illness in patients with sepsis. The receiver operator characteristic curve (ROC curve) was drawn to evaluate the predictive value of each blood lipid component on the 28-day mortality of patients with sepsis. According to the results of ROC curve analysis, the blood lipids were divided into two groups with different levels, and the Kaplan-Meier survival curve was used to compare the cumulative survival rates of the two groups without end-point event (the 28-day mortality was the end-point event).

RESULTS: Compared with non-septic patients, the levels of plasma total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) were significantly lower in patients with sepsis [TC (mmol/L): 2.93±1.33 vs. 4.01±1.14, HDL-C (mmol/L): 0.78±0.47 vs. 1.16±0.40, LDL-C (mmol/L): 1.53±1.00 vs. 2.71±0.98, all P < 0.05]. In patients with sepsis, plasma cholesterol levels were correlated with the degree of inflammation and severity of the disease to varying degrees, but the HDL-C had the strongest correlation with interleukin-6 (IL-6; r = -0.551, P = 0.000), procalcitonin (PCT, r = -0.598, P = 0.000), sequential organ failure assessment (SOFA; r = -0.285, P = 0.000). The ROC curve analysis showed that among all blood lipid components, HDL-C had the highest predictive value for 28-day mortality of sepsis patients, and the area under the ROC curve (AUC) was 0.718, when the best cut-off value was 0.69 mmol/L, the sensitivity and specificity were 67.3% and 65.2% respectively, and the positive predictive value and negative predictive value were 60.6% and 71.5% respectively. According to Kaplan-Meier survival curve analysis, the mortality of sepsis patients with HDL-C ≤ 0.69 mmol/L was significantly higher than the patients with HDL-C > 0.69 mmol/L, and the difference was statistically significant (P < 0.000 1). In addition, the 28-day mortality [59.73% (135/226) vs. 28.70% (64/223)], the incidence of multiple organ dysfunction [41.15% (93/226) vs. 31.84% (71/223)], the probability of requiring mechanical ventilation and vasoactive drugs [mechanical ventilation: 56.64% (128/226) vs. 46.18% (103/223); vasoactive drugs: 54.42% (123/226) vs. 38.57% (86/223)], the positive rate of microbial culture [45.58% (103/226) vs. 35.43% (79/223)], and the probability of drug-resistant bacteria [19.91% (45/226) vs. 10.31% (23/223)] in the low HDL-C group of sepsis patients were all higher than the high HDL-C group, the differences were statistically significant (all P < 0.05).

CONCLUSIONS: Plasma cholesterol levels, especially the HDL-C levels, can well reflect the intensity of inflammation and the severity of the disease in patients with sepsis. And the HDL-C levels can be used as a good biomarker for predicting the short-term prognosis of sepsis.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Xu Y, Wang D, Liu H, et al. [The relationship between the lipid profiles and inflammation in patients with sepsis]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022. PMID: 35387716. doi:10.3760/cma.j.cn121430-20211105-01646

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。